New Funtrition Gummy Manufacturing Facility in Florida Slated to be Fully Operational by Q1 2023, to Support Increased U.S. and global Demand of Advanced Gummy Technologies for the Global Nutraceutical Industry. Expansion Plans Expected to Double Current Capacity, ensuring redundancy in supply to the market, and position manufacturing of a wider product array closer to key current and potential new customers.
- Discover the endless opportunities our Softgel Capsule can offer to your brand.
- Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceuticals, expanding its iCDMO Business Unit.
- The Future of Innovation In Pharmaceutical Delivery Systems
- A Culture of Innovation as a Differentiation